H2N3 MO 2003/AA live-attenuated intranasal vaccine （NIAID）

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH2N3 MO 2003/AA live-attenuated intranasal vaccine （NIAID）
Drug Alias NameH2N3 MO 2003/AAlive attenuated influenza A H2N3 vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)University Of Rochester
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of RochesterNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A